Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-11.58	63.83	72.19
Graham Fair Price	-18.58	13.06	16.04
PEG	14.52	-1.50	1.31
Price/Book	-1.88	4.52	4.60
Price/Cash Flow	-58.09	79.69	-190.12
Prices/Earnings	53.16	53.21	34.74
Price/Sales	-2.20	12.63	12.91
Price/FCF	-58.09	79.69	-190.12
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-5.50	0.50	0.53
Operating Margin	9.00	0.15	0.14
ROA	-34.66	< 0.005	0.01
ROE	0.03	0.02	-35.94
ROIC	0.02	0.03	39.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	0.14	-97.33
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.30	0.11	-62.70
EPS QOQ	0.27	-0.35	33.75
FCF QOQ	-1.31	3.38	158.85
Revenue QOQ	0.06	0.02	-63.13
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	172.76	166.28	-3.75
Days Sales Outstanding (DSO)	56.64	54.15	-4.39
Inventory Turnover	0.52	0.54	3.90
Debt/Capitalization	0.48	0.46	-4.27
Quick Ratio	1.55	1.29	-17.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	18.58	18.90	1.73
Cash	3.84	3.55	-7.54
Capex	-0.44	-0.19	56.57
Free Cash Flow	-0.45	1.07	138.13
Revenue	6.62	6.76	2.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.92	2.56	-12.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.73	8.82	-9.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating